Cargando…

Evaluation of urine biomarkers of kidney injury in Polycystic Kidney Disease

Progressive disruption of renal tubular integrity in the setting of increased cellular proliferation and apoptosis is a feature of ADPKD. Here we evaluated the effect of these processes on the expression of NGAL and IL-18, markers of tubular injury, in rodent models and in the cyst fluid and urine o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parikh, Chirag R., Dahl, Neera K., Chapman, Arlene, Bost, James E., Edelstein, Charles L., Comer, Diane M., Zeltner, Raoul, Tian, Xin, Grantham, Jared J., Somlo, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319327/ https://www.ncbi.nlm.nih.gov/pubmed/22258321 http://dx.doi.org/10.1038/ki.2011.465

Ejemplares similares

Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
por: Kistler, Andreas D., et al.
Publicado: (2013)

Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
por: Kistler, Andreas D., et al.
Publicado: (2013)

Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease
por: Gulati, Ashima, et al.
Publicado: (2023)

Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease
por: Lee, Seung Hun, et al.
Publicado: (2014)

A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease
por: Bhutani, Harpreet, et al.
Publicado: (2015)

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017)

Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease
por: Ma, Ming, et al.
Publicado: (2013)

Restoration of proximal tubule flow–activated transport prevents cyst growth in polycystic kidney disease
por: Du, Zhaopeng, et al.
Publicado: (2021)

Considerations in Controlling for Urine Concentration for Biomarkers of Kidney Disease Progression After Acute Kidney Injury
por: Wen, Yumeng, et al.
Publicado: (2022)

Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression
por: Piazzon, Nathalie, et al.
Publicado: (2015)

Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease
por: Wang, Xiaofang, et al.
Publicado: (2009)

Large Deletions in GANAB and SEC63 Explain 2 Cases of Polycystic Kidney and Liver Disease
por: Wilson, Elena M., et al.
Publicado: (2020)

Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers
por: Sorić Hosman, Iva, et al.
Publicado: (2023)

Urine proteome of autosomal dominant polycystic kidney disease patients
por: Bakun, Magda, et al.
Publicado: (2012)

Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
por: El Ters, Mireille, et al.
Publicado: (2021)

Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease
por: Dad, Taimur, et al.
Publicado: (2018)

Biomarkers of acute kidney injury and associations with short- and long-term outcomes
por: Schaub, Jennifer A., et al.
Publicado: (2016)

Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
por: Kim, Hyun-Jung, et al.
Publicado: (2012)

Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients
por: Hall, Isaac E, et al.
Publicado: (2014)

Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsy
por: Tran, Anna C., et al.
Publicado: (2022)

Urinalysis findings and urinary kidney injury biomarker concentrations
por: Nadkarni, Girish N., et al.
Publicado: (2017)

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017)

Biomarkers of Acute Kidney Injury
por: Sirota, Jeffrey C., et al.
Publicado: (2011)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery
por: Dennen, Paula, et al.
Publicado: (2010)

Urine MicroRNA as Potential Biomarkers of Autosomal Dominant Polycystic Kidney Disease Progression: Description of miRNA Profiles at Baseline
por: Ben-Dov, Iddo Z., et al.
Publicado: (2014)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

Associations of CKD risk factors and longitudinal changes in urine biomarkers of kidney tubules among women living with HIV
por: Muiru, Anthony N., et al.
Publicado: (2021)

Polycystic horseshoe kidney
por: Prasad, A. K., et al.
Publicado: (2013)

Horseshoe polycystic kidney
por: Maple, Hannah, et al.
Publicado: (2013)

Polycystic horseshoe kidney
por: Ram, Rapur, et al.
Publicado: (2013)

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
por: Casteleijn, Niek F., et al.
Publicado: (2016)

Standardised Outcomes in Nephrology—Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease
por: Cho, Yeoungjee, et al.
Publicado: (2017)

Multiple Cerebral Aneurysms in an Adult With Autosomal Recessive Polycystic Kidney Disease
por: Gately, Ryan, et al.
Publicado: (2020)

Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study
por: Muiru, Anthony N., et al.
Publicado: (2019)

A Pilot Study of Urine Proteomics in COVID-19–Associated Acute Kidney Injury
por: Ye, Yinyin, et al.
Publicado: (2021)

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease
por: Tangri, Navdeep, et al.
Publicado: (2017)

Urine Biomarkers of Kidney Tubule Health and Incident CKD Stage 3 in Women Living With HIV: A Repeated Measures Study
por: Ascher, Simon B., et al.
Publicado: (2021)

Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease
por: Bitarafan, Fatemeh, et al.
Publicado: (2019)

COVID-19 and the Kidney: Recent Advances and Controversies
por: Menez, Steven, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2s1j28qcvt577lgs18750kcs7n